Your Location：
Home >
Browse articles >
Jiedu Tongluo Tiaogan Prescription Protects Pancreatic β Cell by Targeting NLRP3 Inflammasome via TGR5/cAMP Signaling Pathway
Jiedu Tongluo Tiaogan Prescription Protects Pancreatic
β Cell by Targeting NLRP3 Inflammasome via TGR5/cAMP Signaling Pathway- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 11, Pages: 95-103(2024)
DOI： 10.13422/j.cnki.syfjx.20232440
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 3 ) Tabs( 7 )
References
Publication Info
Metrics
295
Views
136
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Banxia Baizhu Tianmatang Regulates NLRP3 Inflammasomes to Ameliorate Cognitive Impairment in Epilepsy
Mechanisms of Antidepressant Effect of Zhizi Houpotang and Its Herbal Pairs Based on NLRP3/GSDMD Signaling Pathway
Mechanism of Xiaozheng Zhitong Paste in Alleviating Bone Cancer Pain by Regulating Microglial Pyroptosis Based on PINK1/Parkin/NLRP3 Signaling Pathway
Mechanism of Guihuang Formula in Regulating NLRP3 Inflammasome-mediated Pyroptosis in Treatment of Chronic Prostatitis
Mechanism of Xixintang in Protecting Blood-brain Barrier in Alzheimer's Disease Model Rats Based on AQP4 Polarization
Related Author
ZHU Xingdan
KAI Yinhua
TIAN Rong
YANG Xin
HE Jiayi
GUO Xiangxin
MU Yadong
JIANG Cui
Related Institution
School of Basic Medical Sciences， Chengdu University of Traditional Chinese Medicine
School of Integrative Medicine，Nanjing University of Chinese Medicine
Drum Tower Clinical Medical College， Nanjing University of Chinese Medicine
School of Elderly Care Services and Management， Nanjing University of Chinese Medicine
Faculty of Rehabilitation Science， Nanjing Normal University of Special Education
Intro
Map
Chat
